Association of systemic inflammation with the serum apolipoprotein A-1 level: A cross-sectional pilot study

• Published in: Journal of cardiology Vol. 68; no. 2; pp. 168 - 177
• Main Authors: Tani, Shigemasa, Nagao, Ken, Hirayama, Atsushi
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.08.2016
• Subjects: Aged; Apolipoprotein A-1; Apolipoprotein A-I - blood; Biomarkers - blood; C-Reactive Protein - analysis; Cardiovascular; Coronary artery disease; Coronary Artery Disease - etiology; Cross-Sectional Studies; Female; Follow-Up Studies; High-sensitivity C-reactive protein; Humans; Inflammation - blood; Inflammation - complications; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Peripheral white blood cell count; Pilot Projects; Risk Factors; High-sensitivity C-reactive protein; Coronary artery disease; Peripheral white blood cell count; Apolipoprotein A-1
• ISSN: 0914-5087; 1876-4738; 1876-4738
• DOI: 10.1016/j.jjcc.2015.08.016

There is growing evidence to suggest that measurement of apolipoprotein A-1 (apoA-1), the main surface protein on high-density lipoprotein (HDL) particles, is superior to measurement of the serum HDL-cholesterol level as a predictor of the occurrence of coronary disease (CAD). We investigated the association of systemic inflammation as an initiator of CAD along with the serum apoA-1 level. This study was designed as a hospital-based cross-sectional study on 652 consecutive outpatients with at least one risk factor for CAD to investigate the relationships between the serum high-sensitivity C-reactive protein (hs-CRP) and the peripheral blood white blood cell (WBC) count and the serum apoA-1 level between April 2009 and October 2009. Multivariate analysis after adjustments for traditional coronary risk factors revealed reduced apoA-1 as an independent indicator of higher hs-CRP and WBC count, both in the overall subject population (β: −0.270 and −0.116, p<0.0001 and 0.003) and in a patient subset with serum low-density lipoprotein cholesterol <100mg/dL (β: −0.280 and −0.128, p<0.0001 and 0.045). However, in the patients who could be followed up 6 months later, the increase in the apoA-1 level was associated with a decrease in the hs-CRP level, but not with a decrease in the WBC count. Increased serum apoA-1 levels may be associated with decreased hs-CRP levels and decreased WBC counts as predictive inflammatory biomarkers of the onset of CAD. In particular, increase in the hs-CRP level and decrease in the apoA-1 level may be useful indices of the risk of CAD.